Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Idiopathic Parkinson's DiseaseParkinson's DiseaseBasal Ganglia DiseaseBrain DiseasesCentral Nervous System DiseasesMovement DisordersNervous System DiseasesNeurodegenerative DiseasesParkinsonian DisordersGene TherapyPDAromatic L- Amino Acid DecarboxylaseAADCAAV2-AADCAAV2Viral VectorGene TransferMRIPETVY-AADC01DiseaseParkinson DiseaseBasal Ganglia DiseasesVY-AADC01 Single Dose
Lead Scientist at UCSF
- Paul Larson
Dr. Paul Larson is Professor and Vice Chair of Neurological Surgery at the University of California San Francisco, Chief of Neurosurgery at the San Francisco VA Medical Center and Surgical Director of the Parkinson’s Disease Research, Education and Clinical Center. He specializes in functional neurosurgery, specifically deep brain stimulation for movement disorders and MR-guided procedures.